The key role of IL-6 in determining CRA has been demonstrated in several publications: in particular one publication by us provided the earliest demonstration that IL-6, in conjunction with the stage of disease, represented an independent predictor of Hb values in a cohort of ovarian cancer patients (Macciò et al., 2005). This evidence concerns the gene IL6 and ovarian carcinoma.